Organisation paid for research Program year 2025 Source: CMS Open Payments

Scleroderma Research Foundation

Neither a doctor nor a teaching hospital

Research payments

$25,725,486

15 payments

Through program year 2025, Scleroderma Research Foundation is reported as receiving $25,725,486 in research payments, across 15 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$58,835	1
2024	Research	$13,917,157	8
2023	Research	$11,749,494	6

Breakdown

Who paid Research payments · program years 2023–2025

Sanofi US Services Inc. $25,725,486 15 payments

Studies the money was for Research payments · program years 2023–2025

CONQUEST Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis $25,666,651 14 payments
CONQUEST Platform Clinical Trial for Conquering Scleroderma. A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Platform Clinical Trial Evaluating the Safety and Efficacy of Investigational Products in Patients with Interstitial Lung Dis $58,835 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.